Vice President, Combination Product Quality, Amgen, United States
Dr. Bano is the Vice President of Combination product Quality at Amgen. She is a Physician, with a Masters in Clinical Research (UCSD), Pharmaceutical engineering Certification, a Database Administrator and a certified Project Management Professional. She is an Abbott President’s...
Read More →JH
Head of Benefit Risk Evaluation Team II: Gastrointestinal, Nutrition, Endocrine, Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Jenifer Hannon provides strategic leadership and management within the gastrointestinal system, nutrition, endocrine and fertility therapy areas within the Risk/Benefit function at MHRA. Her overarching objective is to ensure that safe and effective medicines and medical devices...
Read More → 
Sr Director, Risk Management, Global Patient Safety, Alexion Astra Zeneca Rare Disease, United States
Meredith Smith is Risk Management Director at AstraZeneca where she is responsible for medicinal product benefit-risk management for the Alexion Rare Disease Business Unit portfolio. She is a behavioral scientist and health services researcher by training with over 15 years of experience...
Read More →
Associate Director for Policy, Office of Combination Products, OCPP, OC, FDA, United States
John Barlow Weiner is the Associate Director for Policy in the Food and Drug Administration's Office of Combination Products, which is tasked with ensuring the sound and consistent regulation of combination products and also with the classification and assignment for regulation of...
Read More →
Create a custom schedule.
Take it with you on mobile.
Get listed in the directory.
